InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,108.54
(
-0.15%
)
US TECH 100
17,284.00
(
-0.15%
)
Dow Jones
38,171.35
(
-0.56%
)
Brent Oil
85.82
(
-1.68%
)
Bitcoin
60,782.45
(
-4.79%
)

Replies to post #1773 on Conatus Pharmaceuticals Inc. (CNAT)

Replies to #1773 on Conatus Pharmaceuticals Inc. (CNAT)

Lunacy_John Galt

03/11/18 5:37 PM

#1774 RE: Inoviorulez #1773

I believe the primary endpoint is 15% more effective than the placebo.

Lunacy_John Galt

03/11/18 5:59 PM

#1775 RE: Inoviorulez #1773

Also, all 4 Ph2b trials are double blind. No open label studies.